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Nowadays, volumetric and morphometric (VBM) techniques based on
MRI data play a significant role in the research on neurodegenerative dis-
eases. The aim of this work was to present the influence of age and gender
on brain atrophy in patients ail to the most common demyelinating disease
— multiple sclerosis (MS) — in the group of between 20–60-year-olds not
treated with any disease-modifying drugs using VBM methods. MRI data
of 31 patients obtained during the routine clinical work by MAGNETOM
Aera 1.5T scanner were analysed. The faster decline of brain parenchymal
fraction with age was observed in men than in women. VBM results showed
that grey matter loss in significant regions of the brain such as visual cor-
tex, SMA, caudate nucleus and the accumulation of damages can lead to
the disability of patients.
DOI:10.5506/APhysPolBSupp.13.955
1. Introduction
The central nervous system (CNS) is an essential part of the nervous
system in vertebrates and includes brains and the spinal cord. The human
brain divided into two hemispheres is connected by the white matter ag-
gregate called corpus callosum. Each of hemispheres consists of four main
lobes: frontal, parietal, temporal and occipital, on which the cortical surface
functional centres are corresponding to, e.g. for sight, movement, speech.
Unfortunately, the brain undergoes atrophy. The term atrophy determines
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the loss of the brain tissue that occurs in every organism during the natu-
ral ageing process, but in the cases of specific diseases and disorders such
as Alzheimer’s diseases (AD) and Multiple Sclerosis (MS) this process is
faster. The last one became one of the most common demyelinating dis-
orders of the CNS in people between 20–40 year olds. Primary damage of
myelin sheaths and their breakdown results in secondary damage to nerve
fibres, which gradually reduces a patient’s quality of life.
Magnetic resonance imaging (MRI) is essential in the diagnosis of MS,
tracking its progress and monitoring the effects of the drugs therapies. Cur-
rently used MRI sequences allow imaging changes not only in the area of
white matter (WM) but also the grey matter (GM). A significant role in
research on demyelinating diseases played techniques such as volumetric or
morphometric, which based on MRI data. Volumetric analyses allow for
the quantitative assessment of nervous tissue loss and its expression using
the brain parenchymal fraction (BPF), which is calculated as the ratio of
the sum of grey and white matter volume (BPV, brain parenchyma volume)
and total intracranial volume (TIV, sum of GM, WM and CSF). Voxel-based
morphometry (VBM) allows to indicate local differences in brain anatomy
using a statistical approach to parametric mapping. VBM results for the
healthy are well-defined [1, 2], however, analyses for neurodegenerative dis-
eases are still under discussion. The purpose of the work is to present the
impact of the age and gender on brain atrophy in patients ail to multiple
sclerosis between 20 and 60 years old using volumetric and morphometric
analyses.
2. Materials and methods
The studied group consisted of 31 patients with diagnosed MS (ICD-10,
G35) before starting therapy. The average patients age was 40.23 ± 9.6
years. The group consisted of 23 females and 8 males and their mean age
was 38.96± 7.6 and 43.9± 11.9 years, respectively. The control group con-
sisted of 6 neurologically healthy volunteers and their mean age was 24.5±2.2
years. Unfortunately, due to the profile of the medical facility, it was not
possible to gather a large control group sufficiently varied in age. Hence,
the decision to choose a control group that matches the age of MS patients
from literature [3]. Brain MRI was performed on a Siemens 1.5T MAGNE-
TOM Aera scanner using a 20-channel head-neck coil in Helimed Diagnostic
Imaging Center as a part of routine clinical work. FLAIR (TR = 5000 ms,
TE = 334 ms, TI = 1800 ms, ST = 1.1 mm) and T1 MPRAGE before and
after gadolinium-based contrast injection (TR = 1900 ms, TE = 2.97 ms,
TI = 1100 ms, ST = 1.0 mm) sequences were acquired.
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The VBM procedure was performed in the SPM12 in MATLAB. All raw
T1 brain images were segmented into GM, WM and CSF volumes using
tissue probability maps. Subsequently, GM volumes were normalised to the
standard MNI (Montreal Neurological Institute) space using the DARTEL
toolbox. The study-specific group brain template was created for analy-
sis. The individual volumes were modulated by the total brain volume and
smoothed using 8 mm FWHM Gaussian kernel. To analyse global changes
in GM across the whole brain, the statistical tests were performed. The
multiple regression test was used to check which regions had proportionally
less grey matter depending on age and the two-sample t-test was utilized
to check the impact of sex and to find statistically significant differences
between brain regions. Subsequently, the dependent one-sample t-test was
performed in Statistica 13 to estimate results against age. The Shapiro–Wilk
test was used to check the normality of the distributions and the homogene-
ity of the variance. The significant results were regarded for differences for
p < 0.05.
3. Results
Figure 1 presents BPF values of MS patients as a function of age with
a linear fit of data. Calculated mean BPF value (0.87 ± 0.01) is similar
to results reported for other MS patients groups [3, 4] (for example, BPF
= 0.85± 0.01 was reported by Vågberg et al. [3]) and lower than in healthy
adults e.g. 0.89±0.01 [3]. It is interesting that in our study, values of BPF in
young MS patients (at the beginning of the disease) were comparable with
results of our control group consisted of young people. It was also noticeable
that brain tissue loss in our middle age patients group is comparably fast to
that in healthy elderly [5].
Fig. 1. BPF values of MS patients.
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Calculated Pearson’s correlation coefficient of BPF with age in MS pa-
tients showed value r = −0.56 which is slightly lower than mean population
BPF parameter (r = −0.41) for healthy adults [2]. Additionally calculated
correlations between BPF and age separately for females and males, re-
spectively −0.42 and −0.66, showed a decline BPF with age in each group.
Therefore, it seems that the atrophy process is faster in men than in women
suffer from MS and there are differences between gender, which were ob-
served in healthy adults [1, 5]. Nevertheless, due to small patients group our
study has limitations that should be considered when interpreting our re-
sults.
In addition, BPF checked the distribution of brains fractions normalised
by TIV as a function of age. A slight change in WM volume was observed
(r = −0.09) unlike to GM and CSF (respectively −0.52 and 0.56) (Fig. 2).
The marked decrease of GM volume and increase of CSF volume with age is
in agreement with results reported by Smith et al. [5]. Moreover, decrease
of BPV lead to the widening of the subarachnoid cranial space and brain
reservoirs [5], which increases CSF volume [1].
Fig. 2. Distribution of GM/TIV (a) and CSF/TIV (b) for MS patients in relations
to age with a linear fit of data.
In this paper, we focused on the regional effects of the brain atrophy in
MS patients. Figure 3 presents regions of the cerebral cortex with increased
atrophy. Accelerated GM loss was observed bilaterally in frontal gyrus (su-
perior and middle), right superior parietal gyrus, and supplementary motor
area (SMA) like in healthy adults [1]. In MS patients, atrophy in deep GM
structures such as the insula and caudate nucleus was also observed. In the
studied group, GM loss in the thalamus was not observed.
Moreover, extracted regional grey matter loss differs between genders.
Compared to females, in males GM loss in the cerebellum, middle cingulate
gyrus and precuneus was observed what was also reported earlier for healthy
men [6]. Additionally, accelerated grey matter atrophy in areas such as
lingual gyrus, occipital pole and middle occipital gyrus, parahippocampal
gyrus, frontal gyrus (middle), and deep grey matter structures as caudate
nucleus and hippocampus was detected similarly as was mentioned by [7].
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Fig. 3. VBM results. Regions with reduced grey matter in patients with SM with
age presented on the average template of the studied group. The axial plane,
significant voxels (p < 0.001).
4. Discussion
In this study, we focused on the influence of age and sex on the brain
atrophy in patients who have multiple sclerosis. The role of MRI in MS
diagnostics is indisputable and possibilities of imaging sequences which pro-
vide demyelinating plaques imaging are not limited only to WM but also
GM [8–11]. Nowadays, a significant role in research on neurodegenerative
diseases play morphometric analyses which provide an opportunity to know
better which regions of the brain in higher degree undergo the atrophy, but
also volumetric analysis which increases diagnostics and allows monitoring
of applied drugs therapies [12]. It was known that the physiological process
of neural tissue loss depends on age [1] or sex [5] in healthy people as well
as attendant neurodegenerative disorders like MS [13] or AD [14] which can
accelerate neural tissue loss and our results confirm that. Atrophy process
occurs in different brain areas and our VBM results are consistent with other
results [7]. It is also worth noting that there are significant differences in re-
gional GM loss in MS patients compared to healthy control [1, 5]. In addition
to cortical changes i.e. in occipital pole [15], in MS patients we observed GM
loss in deep grey matter structures analogously as showed [16–18] in their
work, what is more interesting. Caudate nucleus, insula, parahippocampal
gyrus and hippocampus the atrophy of which was observed are functionally
responsible for e.g. sensory and motor functions, cognitive and affective pro-
cessing [19, 20]. The loss of GM in these regions could give early symptoms
of the disease.
Considering the impact of gender on global as well as regional effects of
brain atrophy, literature shows that sex has no significant effect for GM loss
for the healthy [1, 5]. However, for MS patients, the results indicated sig-
nificant gender differences in early relapsing-remitting MS [21]. Our results
also showed the sex differences in global and regional brain atrophy effects.
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Limitation of our work was a relatively small patients group, but our
results are generally consistent with other MS studies [4]. Of course, there
are works whose results differ significantly from ours but this can be due to
the applied methodology [2, 12, 22, 23].
5. Conclusion
Our study confirms the decline of the BPF with age which is faster in MS
patients than in healthy adults. However, the volume of WM, GM and CSF
changes to a different degree and is dependent on sex. Especially in the case
of GM atrophy in men, this process is faster than in women. The differences
we observe mainly concern GM loss and the increase of CSF with relatively
small changes of WM. VBM results show that GM loss in the vital regions
(visual cortex, SMA, caudate nucleus) of the brain and this accumulation of
damages lead to the disability of patients.
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